The annual J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' ...
Absent any statutory consequences for not completing the OPPS Drug Acquisition Cost Survey (ODACS), it is wrong for CMS to tell hospitals and health systems that they “are to” complete it.